EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT1D Receptor Activation via NO Pathway

Juan Francisco Fernández-González, José Ángel García-Pedraza iD, José Luis Ordóñez, Anaïs Clara Terol-Úbeda iD, María Luisa Martín iD, Asunción Morán, Mónica García-Domingo iD

International Journal of Molecular Sciences · 10.01.2023 · 24 (2) · 1378

DOI: 10.3390/ijms24021378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.01.2023. Verfasst von Juan Francisco Fernández-González und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Farmacología, Departamento de Fisiología y Farmacología, Facultad de Farmacia, Universidad de Salamanca, 37007 Salamanca, Spain. Hauptthemen laut MEDLINE: Serotonin, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Salamanca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal vasculature, which is highly innervated by sympathetic fibers, contributes to cardiovascular homeostasis. This renal sympathetic outflow is inhibited by 5-HT in normoglycaemic rats. Considering that diabetes induces cardiovascular complications, we aimed to determine whether diabetic state modifies noradrenergic input at renal level and its serotonergic modulation in rats. Alloxan diabetic rats were anaesthetized (pentobarbital; 60 mg/kg i.p.) and prepared for in situ autoperfusion of the left kidney to continuously measure systemic blood pressure (SBP), heart rate (HR), and renal perfusion pressure (RPP). Electrical stimulation of renal sympathetic outflow induces frequency-dependent increases (Δ) in RPP (23.9 ± 2.1, 59.5 ± 1.9, and 80.5 ± 3.5 mm Hg at 2, 4, and 6 Hz, respectively), which were higher than in normoglycaemic rats, without modifying HR or SBP. Intraarterial bolus of 5-HT and 5-CT (5-HT1/5/7 agonist) reduced electrically induced ΔRPP. Only L-694,247 (5-HT1D agonist) reproduced 5-CT inhibition on sympathetic-induced vasoconstrictions, whereas it did not modify exogenous noradrenaline-induced ΔRPP. 5-CT inhibition was exclusively abolished by i.v. bolus of LY310762 (5-HT1D antagonist). An inhibitor of guanylyl cyclase, ODQ (i.v.), completely reversed the L-694,247 inhibitory effect. In conclusion, diabetes induces an enhancement in sympathetic-induced vasopressor responses at the renal level. Prejunctional 5-HT1D receptors, via the nitric oxide pathway, inhibit noradrenergic-induced vasoconstrictions in diabetic rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SerotoninDiabetes Mellitus, ExperimentalRatsAnimalsRats, WistarReceptor, Serotonin, 5-HT1DKidneyNorepinephrineSympathetic Nervous SystemElectric StimulationBlood PressureOxadiazolesTryptamines

Stichwörter der Autor:innen

5-HT1D receptordiabetesdiabetic complicationsrenal vasculaturesympathetic neurotransmissionvasopressor responses

Substanzen

SerotoninReceptor, Serotonin, 5-HT1DNorepinephrineL 694247OxadiazolesTryptamines

Autor:innen und Institutionen

  • Laboratorio de Farmacología, Departamento de Fisiología y Farmacología, Facultad de Farmacia, Universidad de Salamanca, 37007 Salamanca, Spain.
  • Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo San Vicente 58-182, 37007 Salamanca, Spain.

ORCID-Profile: José Ángel García-Pedraza, Anaïs Clara Terol-Úbeda, María Luisa Martín, Mónica García-Domingo

Förderung

  • University of Salamanca

Zitieren

APA

Fernández-González, J. F., García-Pedraza, J. Á., Ordóñez, J. L., Terol-Úbeda, A. C., Martín, M. L., Morán, A., & García-Domingo, M. (2023). Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT1D Receptor Activation via NO Pathway. International Journal of Molecular Sciences, 24(2), 1378. https://doi.org/10.3390/ijms24021378

Vancouver

Fernández-González JF, García-Pedraza JÁ, Ordóñez JL, Terol-Úbeda AC, Martín ML, Morán A, et al. Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT1D Receptor Activation via NO Pathway. International Journal of Molecular Sciences. 2023;24(2):1378. doi:10.3390/ijms24021378

BibTeX
@article{FernndezGonzlez2023,
  author = {Fernández-González, Juan Francisco and García-Pedraza, José Ángel and Ordóñez, José Luis and Terol-Úbeda, Anaïs Clara and Martín, María Luisa and Morán, Asunción and García-Domingo, Mónica},
  title = {Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT1D Receptor Activation via NO Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {2},
  pages = {1378},
  doi = {10.3390/ijms24021378}
}
Kostenlos starten →